Ten-year costs of cardiovascular disease in genetically verified familial hypercholesterolaemia compared with age- and sex-matched controls - Quiz - MDSpire

Ten-year costs of cardiovascular disease in genetically verified familial hypercholesterolaemia compared with age- and sex-matched controls

  • By

  • Torbjørn Wisløff

  • Liv J Mundal

  • Jannicke Igland

  • Karianne Svendsen

  • Martin Prøven Bogsrud

  • Ivar Sønbø Kristiansen

  • Kjetil Retterstøl

  • September 23, 2025

  • 0 min

Share

Original Source(s)

Ten-year costs of cardiovascular disease in genetically verified familial hypercholesterolaemia compared with age- and sex-matched controls

  • by Torbjørn Wisløff, Liv J Mundal, Jannicke Igland, Karianne Svendsen, Martin Prøven Bogsrud, Ivar Sønbø Kristiansen, Kjetil Retterstøl

  • September 23, 2025

Related Content

Invasive NSTEMI Strategy Shows No Benefit in Frail Patients

Frailty severity may identify older patients least likely to benefit—and potentially at higher risk—with invasive management.

Multicenter development and validation of machine-learning risk models to predict procedural complete revascularization and in-hospital heart failure in STEMI patients treated with primary PCI

Assessment of Safety and Efficacy of Varying Durations of Dual Antiplatelet Therapy with Aspirin and Ticagrelor Following Successful Percutaneous Coronary Intervention in Diabetic Patients with Acute Coronary Syndrome